Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation.

NCT02590432 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT02590432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02590432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation.
Lead sponsor
Forest Laboratories
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2015
Completion date
February 5, 2018
Enrollment
828 (actual)
Sites
79

Conditions

As the registry lists them; a condition with its own page is linked.

chronic idiopathic constipation, irritable bowel syndrome with constipation